Journal Article
. 2019 May; 116(23):11390-11395.
doi: 10.1073/pnas.1902645116.

Aneuploidy drives lethal progression in prostate cancer

Konrad H Stopsack 1 Charles A Whittaker 2 Travis A Gerke 3 Massimo Loda 4 Philip W Kantoff 1 Lorelei A Mucci 5 Angelika Amon 6 
Affiliations
  • PMID: 31085648
  •     36 References
  •     16 citations

Abstract

Aneuploidy, defined as chromosome gains and losses, is a hallmark of cancer. However, compared with other tumor types, extensive aneuploidy is relatively rare in prostate cancer. Thus, whether numerical chromosome aberrations dictate disease progression in prostate cancer patients is not known. Here, we report the development of a method based on whole-transcriptome profiling that allowed us to identify chromosome-arm gains and losses in 333 primary prostate tumors. In two independent cohorts (n = 404) followed prospectively for metastases and prostate cancer-specific death for a median of 15 years, increasing extent of tumor aneuploidy as predicted from the tumor transcriptome was strongly associated with higher risk of lethal disease. The 23% of patients whose tumors had five or more predicted chromosome-arm alterations had 5.3 times higher odds of lethal cancer (95% confidence interval, 2.2 to 13.1) than those with the same Gleason score and no predicted aneuploidy. Aneuploidy was associated with lethality even among men with high-risk Gleason score 8-to-10 tumors. These results point to a key role of aneuploidy in driving aggressive disease in primary prostate cancer.

Keywords: aneuploidy; lethal disease; prostate cancer; transcriptome.

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.
W G Christen, J M Gaziano, C H Hennekens.
Ann Epidemiol, 2000 Feb 26; 10(2). PMID: 10691066
Highly Cited. Review.
The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis.
J L Phillips, S W Hayward, +10 authors, T Ried.
Cancer Res, 2001 Nov 24; 61(22). PMID: 11719443
Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.
Madhvi B Upender, Jens K Habermann, +4 authors, Thomas Ried.
Cancer Res, 2004 Oct 07; 64(19). PMID: 15466185    Free PMC article.
Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.
Edward Giovannucci, Yan Liu, +2 authors, Walter C Willett.
Int J Cancer, 2007 Apr 24; 121(7). PMID: 17450530    Free PMC article.
Highly Cited.
Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells.
Bret R Williams, Vineet R Prabhu, +4 authors, Angelika Amon.
Science, 2008 Nov 01; 322(5902). PMID: 18974345    Free PMC article.
Highly Cited.
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
Jennifer R Stark, Sven Perner, +10 authors, Lorelei A Mucci.
J Clin Oncol, 2009 May 13; 27(21). PMID: 19433685    Free PMC article.
Highly Cited.
Chromosomal instability determines taxane response.
Charles Swanton, Barbara Nicke, +19 authors, Julian Downward.
Proc Natl Acad Sci U S A, 2009 May 22; 106(21). PMID: 19458043    Free PMC article.
Highly Cited.
The landscape of somatic copy-number alteration across human cancers.
Rameen Beroukhim, Craig H Mermel, +59 authors, Matthew Meyerson.
Nature, 2010 Feb 19; 463(7283). PMID: 20164920    Free PMC article.
Highly Cited.
Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, +23 authors, William L Gerald.
Cancer Cell, 2010 Jun 29; 18(1). PMID: 20579941    Free PMC article.
Highly Cited.
The consequences of chromosomal aneuploidy on the transcriptome of cancer cells.
Thomas Ried, Yue Hu, +3 authors, Jordi Camps.
Biochim Biophys Acta, 2012 Mar 20; 1819(7). PMID: 22426433    Free PMC article.
Review.
A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis.
Jason M Sheltzer.
Cancer Res, 2013 Sep 18; 73(21). PMID: 24041940    Free PMC article.
Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors.
Alain D Silk, Lauren M Zasadil, +3 authors, Beth A Weaver.
Proc Natl Acad Sci U S A, 2013 Oct 18; 110(44). PMID: 24133140    Free PMC article.
Highly Cited.
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.
Teresa Davoli, Andrew Wei Xu, +4 authors, Stephen J Elledge.
Cell, 2013 Nov 05; 155(4). PMID: 24183448    Free PMC article.
Highly Cited.
Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Matthew K Tollefson, R Jeffrey Karnes, +5 authors, Thomas J Sebo.
Mayo Clin Proc, 2014 Feb 04; 89(3). PMID: 24486077
Copy number alteration burden predicts prostate cancer relapse.
Haley Hieronymus, Nikolaus Schultz, +14 authors, Charles L Sawyers.
Proc Natl Acad Sci U S A, 2014 Jul 16; 111(30). PMID: 25024180    Free PMC article.
Highly Cited.
Single cell sequencing reveals low levels of aneuploidy across mammalian tissues.
Kristin A Knouse, Jie Wu, Charles A Whittaker, Angelika Amon.
Proc Natl Acad Sci U S A, 2014 Sep 10; 111(37). PMID: 25197050    Free PMC article.
Highly Cited.
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Emilie Lalonde, Adrian S Ishkanian, +39 authors, Robert G Bristow.
Lancet Oncol, 2014 Dec 03; 15(13). PMID: 25456371
Highly Cited.
Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes.
Megan E Bonney, Hisao Moriya, Angelika Amon.
Genes Dev, 2015 May 03; 29(9). PMID: 25934502    Free PMC article.
The Molecular Taxonomy of Primary Prostate Cancer.
Cancer Genome Atlas Research Network.
Cell, 2015 Nov 07; 163(4). PMID: 26544944    Free PMC article.
Highly Cited.
Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer.
Mark A Rubin, Gabriele Girelli, Francesca Demichelis.
Eur Urol, 2015 Nov 14; 69(4). PMID: 26563871
Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.
Håvard E Danielsen, Manohar Pradhan, Marco Novelli.
Nat Rev Clin Oncol, 2015 Nov 26; 13(5). PMID: 26598944
Review.
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Thomas U Ahearn, Andreas Pettersson, +16 authors, Tamara L Lotan.
J Natl Cancer Inst, 2015 Nov 29; 108(2). PMID: 26615022    Free PMC article.
Highly Cited.
Final report on the aspirin component of the ongoing Physicians' Health Study.
Steering Committee of the Physicians' Health Study Research Group.
N Engl J Med, 1989 Jul 20; 321(3). PMID: 2664509
Highly Cited.
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.
Kathryn L Penney, Andreas Pettersson, +6 authors, Lorelei A Mucci.
Cancer Epidemiol Biomarkers Prev, 2016 Mar 05; 25(5). PMID: 26941365    Free PMC article.
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms.
Yu Liu, Chong Chen, +15 authors, Scott W Lowe.
Nature, 2016 Mar 17; 531(7595). PMID: 26982726    Free PMC article.
Highly Cited.
Prognostic Utility of a New mRNA Expression Signature of Gleason Score.
Jennifer A Sinnott, Sam F Peisch, +8 authors, Kathryn L Penney.
Clin Cancer Res, 2016 Sep 25; 23(1). PMID: 27663590    Free PMC article.
Single-chromosome Gains Commonly Function as Tumor Suppressors.
Jason M Sheltzer, Julie H Ko, +7 authors, Angelika Amon.
Cancer Cell, 2017 Jan 17; 31(2). PMID: 28089890    Free PMC article.
Highly Cited.
The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies.
Andreas Pettersson, Travis Gerke, +8 authors, Transdisciplinary Prostate Cancer Partnership (ToPCaP).
Cancer, 2017 Feb 06; 123(9). PMID: 28152172    Free PMC article.
Review.
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
Silke Gillessen, Gerhardt Attard, +58 authors, Aurelius Omlin.
Eur Urol, 2017 Jun 29; 73(2). PMID: 28655541
Highly Cited.
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
Niedzica Camacho, Peter Van Loo, +54 authors, Daniel S Brewer.
PLoS Genet, 2017 Sep 26; 13(9). PMID: 28945760    Free PMC article.
MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.
Andreas Pettersson, Travis Gerke, +8 authors, Massimo Loda.
Cancer Epidemiol Biomarkers Prev, 2017 Nov 17; 27(2). PMID: 29141848    Free PMC article.
The Epidemiology of Prostate Cancer.
Claire H Pernar, Ericka M Ebot, Kathryn M Wilson, Lorelei A Mucci.
Cold Spring Harb Perspect Med, 2018 Jan 10; 8(12). PMID: 29311132    Free PMC article.
Highly Cited. Review.
Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
Alison M Taylor, Juliann Shih, +12 authors, Matthew Meyerson.
Cancer Cell, 2018 Apr 07; 33(4). PMID: 29622463    Free PMC article.
Highly Cited.
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
David C Wedge, Gunes Gundem, +85 authors, Rosalind A Eeles.
Nat Genet, 2018 Apr 18; 50(5). PMID: 29662167    Free PMC article.
Highly Cited.
Genome doubling shapes the evolution and prognosis of advanced cancers.
Craig M Bielski, Ahmet Zehir, +17 authors, Barry S Taylor.
Nat Genet, 2018 Jul 18; 50(8). PMID: 30013179    Free PMC article.
Highly Cited.
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.
Haley Hieronymus, Rajmohan Murali, +12 authors, Charles L Sawyers.
Elife, 2018 Sep 05; 7. PMID: 30178746    Free PMC article.
Highly Cited.
Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis.
David L Newman, Stephen L Gregory.
Int J Mol Sci, 2019 Sep 22; 20(18). PMID: 31540349    Free PMC article.
Review.
Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications.
Matthew J Ryan, Rohit Bose.
Front Oncol, 2019 Dec 12; 9. PMID: 31824860    Free PMC article.
Review.
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Sebastià Franch-Expósito, Laia Bassaganyas, +8 authors, Jordi Camps.
Elife, 2020 Jan 16; 9. PMID: 31939734    Free PMC article.
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Eric T Miller, Sungyong You, +12 authors, Isla P Garraway.
BMC Cancer, 2020 May 10; 20(1). PMID: 32380981    Free PMC article.
Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.
Konrad H Stopsack, Subhiksha Nandakumar, +14 authors, Wassim Abida.
Clin Cancer Res, 2020 Mar 30; 26(13). PMID: 32220891    Free PMC article.
Chromosome Abnormalities: New Insights into Their Clinical Significance in Cancer.
Fan Kou, Lei Wu, Xiubao Ren, Lili Yang.
Mol Ther Oncolytics, 2020 Jul 09; 17. PMID: 32637574    Free PMC article.
Review.
Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.
Konrad H Stopsack, Travis Gerke, +10 authors, Lorelei A Mucci.
Carcinogenesis, 2020 Jun 20; 41(7). PMID: 32556091    Free PMC article.
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
Lisa M Butler, Ylenia Perone, +6 authors, Johannes V Swinnen.
Adv Drug Deliv Rev, 2020 Jul 28; 159. PMID: 32711004    Free PMC article.
Review.
Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.
John Michael Replogle, Wen Zhou, +9 authors, Angelika Amon.
Proc Natl Acad Sci U S A, 2020 Nov 19; 117(48). PMID: 33203674    Free PMC article.
Aneuploidy as a promoter and suppressor of malignant growth.
Anand Vasudevan, Klaske M Schukken, +3 authors, Jason M Sheltzer.
Nat Rev Cancer, 2021 Jan 13; 21(2). PMID: 33432169
Review.
Striking heterogeneity of somatic L1 retrotransposition in single normal and cancerous gastrointestinal cells.
Katsumi Yamaguchi, Alisha O Soares, +8 authors, Haig H Kazazian.
Proc Natl Acad Sci U S A, 2020 Dec 06; 117(51). PMID: 33277430    Free PMC article.
Survival outcomes are associated with genomic instability in luminal breast cancers.
Lydia King, Andrew Flaus, Emma Holian, Aaron Golden.
PLoS One, 2021 Feb 04; 16(2). PMID: 33534788    Free PMC article.
Karyotype Aberrations in Action: The Evolution of Cancer Genomes and the Tumor Microenvironment.
Nicolaas C Baudoin, Mathew Bloomfield.
Genes (Basel), 2021 May 01; 12(4). PMID: 33921421    Free PMC article.
Review.
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Shixiang Wang, Huimin Li, +6 authors, Xue-Song Liu.
PLoS Genet, 2021 May 05; 17(5). PMID: 33945534    Free PMC article.
Context is everything: aneuploidy in cancer.
Uri Ben-David, Angelika Amon.
Nat Rev Genet, 2019 Sep 25; 21(1). PMID: 31548659
Review.
Transient genomic instability drives tumorigenesis through accelerated clonal evolution.
Ofer Shoshani, Bjorn Bakker, +15 authors, Don W Cleveland.
Genes Dev, 2021 Jul 17; 35(15-16). PMID: 34266887    Free PMC article.